Gene-edited healthy donor CAR T cells show superior anti-tumour activity compared to CAR T cells derived from patients with lymphoma in an in vivo model of high-grade lymphoma. (2021)

First Author: Graham CE
Attributed to:  Second Generation Bio-Lentivir Packaging Cell Line for Facile Lentivirus Production funded by EPSRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1038/s41375-021-01324-z

PubMed Identifier: 34145373

Publication URI: http://europepmc.org/abstract/MED/34145373

Type: Journal Article/Review

Volume: 35

Parent Publication: Leukemia

Issue: 12

ISSN: 0887-6924